1. RSV Bronchiolitis

3. Program Goals

4. Incidence of RSV Infection

5. RSV Morbidity and Mortality

6. High-Risk Infants and Children

7. Pathophysiology of RSV Infection

8. Clinical Presentation of RSV Illness

9. Differential Diagnosis of RSV Bronchiolitis

10. Laboratory Diagnosis

11. Pulmonary Sequelae of RSV Bronchiolitis

12. Pulmonary Sequelae of RSV Bronchiolitis (cont)

13. Treatment of RSV Bronchiolitis

14. Treatment of RSV Bronchiolitis (cont)

15. Treatment of RSV Bronchiolitis (cont)

16. Preventing RSV Illness

17. Efficacy of Palivizumab

18. Efficacy of Palivizumab (cont)

19. Candidates for Immunoprophylaxis

20. Candidates for Immunoprophylaxis (cont)

21. Maximum Number of Monthly Doses of Palivizumab

22. Maximum Number of Monthly Doses of Palivizumab (cont)

23. Does Immunoprophylaxis Protect Against Subsequent Wheezing?

24. Passive Smoking and RSV Risk

25. Abbreviations